These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 25723110

  • 1. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J, McCluggage WG.
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [Abstract] [Full Text] [Related]

  • 2. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
    Ding XH, Tian X, Wang LQ, Wang Y, Liu AJ.
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun 08; 49(6):588-593. PubMed ID: 32486536
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ.
    Am J Surg Pathol; 2002 Dec 08; 26(12):1529-41. PubMed ID: 12459620
    [Abstract] [Full Text] [Related]

  • 4. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
    Idrees R, Din NU, Siddique S, Fatima S, Abdul-Ghafar J, Ahmad Z.
    J Ovarian Res; 2021 Mar 18; 14(1):47. PubMed ID: 33736662
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic study of seromucinous carcinoma of ovary].
    Tang SX, Sun YH, Xu Y, Zhou XR, Yang WT.
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov 08; 45(11):774-779. PubMed ID: 27821232
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2016 Mar 08; 40(3):302-12. PubMed ID: 26551621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
    Karpathiou G, Chauleur C, Corsini T, Venet M, Habougit C, Honeyman F, Forest F, Peoc'h M.
    Ann Diagn Pathol; 2017 Apr 08; 27():28-33. PubMed ID: 28325358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG, Young RH.
    Am J Surg Pathol; 2008 Sep 08; 32(9):1373-9. PubMed ID: 18670351
    [Abstract] [Full Text] [Related]

  • 12. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B, Deodhar KK, Menon S, Maheshwari A, Bajpai J, Ghosh J, Shylasree ST, Gupta S.
    APMIS; 2018 Jan 08; 126(1):45-55. PubMed ID: 29266433
    [Abstract] [Full Text] [Related]

  • 13. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M.
    Am J Surg Pathol; 2017 May 08; 41(5):685-695. PubMed ID: 28125452
    [Abstract] [Full Text] [Related]

  • 14. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
    Bell KA, Kurman RJ.
    Am J Surg Pathol; 2000 Nov 08; 24(11):1465-79. PubMed ID: 11075848
    [Abstract] [Full Text] [Related]

  • 15. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P.
    Oncology (Williston Park); 2016 Feb 08; 30(2):166-76. PubMed ID: 26892153
    [Abstract] [Full Text] [Related]

  • 16. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
    Hu Y, Fu K, Liu H, He Q, Qiu X, Yang W, Zhang Y.
    J Ovarian Res; 2023 Jan 20; 16(1):18. PubMed ID: 36670456
    [Abstract] [Full Text] [Related]

  • 17. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
    Ates Ozdemir D, Usubutun A.
    Pathol Oncol Res; 2016 Jul 20; 22(3):593-9. PubMed ID: 26797858
    [Abstract] [Full Text] [Related]

  • 18. Seromucinous Tumors of the Ovary. What's in a Name?
    Kurman RJ, Shih IeM.
    Int J Gynecol Pathol; 2016 Jan 20; 35(1):78-81. PubMed ID: 26598986
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M, Ohishi Y, Oda Y, Misumi M, Iwasa A, Kurihara S, Nishimura I, Okuma E, Kobayashi H, Wake N, Tsuneyoshi M.
    Hum Pathol; 2009 Jul 20; 40(7):965-74. PubMed ID: 19269675
    [Abstract] [Full Text] [Related]

  • 20. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
    Okumura T, Muronosono E, Tsubuku M, Terao Y, Takeda S, Maruyama M.
    J Ovarian Res; 2018 Sep 03; 11(1):77. PubMed ID: 30176911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.